Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Healthcare Cannabis Health Care Cannabis
Nextleaf is a federally regulated manufacturer and distributor of cannabis vapes and oils under its prohibition-era brand, Glacial Gold. The Company’s multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Nextleaf is a low-cost producer of cannabis oils, and supplies THC and CBD ingredients to partners across Canada. Nextleaf has been issued 19 U.S. patents and over 100 patents globally, on cannabinoid processing.


CSE:OILS - Post by User

Nextleaf Solutions Ltd > Greywood Partners Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(582)
•••
Comment by shnepson Aug 27, 2021 8:34am
160 Views
Post# 33774937

RE:RE:RE:RE:RE:RE:RE:Greywood Partners Inc.

RE:RE:RE:RE:RE:RE:RE:Greywood Partners Inc.The patents are only exclusive for twenty years.
GW Pharma generates $577M a year in revenue and has a stable of upcoming prharmaceuticals. That's why it sold for $7B.
We are currently at the very beginning of our revenue growth and are no where near having a $1B valuation. It needs to be proven.
In relation to Greywood Partners "selling" the company I may have been incorrect in they were hired to find a buyer. They may have been hired to find the likes of "Glacial Gold" for an acquistition.
Maybe Jason couuld clarify for us. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities